These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
UTAH
|
87-0496850
|
|
(State or other jurisdiction of
|
(I.R.S. Employer Identification No.)
|
|
Incorporation or organization)
|
|
Large accelerated filer
|
o
|
Accelerated filer
|
o
|
|
Non-accelerated filer
|
o
|
Smaller reporting company
|
x
|
|
(Do not check if a smaller reporting company)
|
|
Class
|
Outstanding as of November 12, 2010
|
|
35,031,558
|
Common Stock, $0.001 par value
|
|
Heading
|
Page
|
|
PART I — FINANCIAL INFORMATION
|
|
|
3
|
|
|
Item 1. Financial Statements
|
|
|
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
|
11
|
|
Item 3. Quantitative and Qualitative Disclosures About Market Risk
|
13
|
|
Item 4(T). Controls and Procedures
|
13
|
|
PART II — OTHER INFORMATION
|
|
|
Item 1. Legal Proceedings
|
13
|
|
Item 1A. Risk Factors
|
14
|
|
Item 2 Unregistered Sales of Equity Securities and Use of Proceeds
|
14
|
|
Item 3. Defaults Upon Senior Securities
|
14
|
|
Item 4. Submission of Matters to a Vote of Securities Holders
|
14
|
|
Item 5. Other Information
|
14
|
|
Item 6. Exhibits
|
14
|
|
Signatures
|
15
|
| BRAIN TREE INTERNATIONAL, INC. | ||||||||
| (A Development Stage Company) | ||||||||
| BALANCE SHEETS | ||||||||
| September 30, 2010 and June 30, 2010 | ||||||||
| (UNAUDITED) | ||||||||
| September 30, 2010 | June 30, 2010 | |||||||
|
CURRENT ASSETS
|
||||||||
|
Cash
|
$ 3,267
|
$ 5,338
|
||||||
|
|
Total Current Assets
|
3,267
|
5,338
|
|||||
|
PATENTS PENDING -
net
|
9,447
|
9,636
|
||||||
|
Total Assets
|
$ 12,714
|
$ 14,974
|
||||||
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
||||||||
|
CURRENT LIABILITIES
|
||||||||
|
Notes Payable-related party
|
65,000
|
65,000
|
||||||
|
Accrued interest payable-related party
|
12,510
|
11,188
|
||||||
|
Accounts payable
|
5,550
|
3,014
|
||||||
|
Total Current Liabilities
|
83,060
|
79,202
|
||||||
|
STOCKHOLDERS' DEFICIENCY
|
||||||||
|
Preferred Stock
|
||||||||
|
3,000,000 shares authorized at $.001 par value;
|
||||||||
|
none outstanding
|
||||||||
|
Common stock
|
|
|||||||
|
47,000,000 shares authorized, at $.001 par value;
|
||||||||
|
35,031,558 shares issued and outstanding
|
35,032
|
35,032
|
||||||
|
Capital in excess of par value
|
129,246
|
129,246
|
||||||
|
Accumulated deficit during development stage
|
(234,624)
|
(228,506)
|
||||||
|
Total Stockholders' Deficiency
|
(70,346)
|
(64,228)
|
||||||
|
$12,714
|
$14,974
|
|||||||
| The accompanying notes are an integral part of these financial statements. | ||||||||
| BRAIN TREE INTERNATIONAL, INC. | |||||||||||||
| (A Development Stage Company) | |||||||||||||
| STATEMENTS OF OPERATIONS - unaudited | |||||||||||||
| For the Three Months Ended September 30, 2010 and 2009 | |||||||||||||
| and the period July 26, 1983 (date of inception) to September 30, 2010 | |||||||||||||
| July 26, 1983 | |||||||||||||
| to | |||||||||||||
| September 30, 2010 | September 30, 2009 | September 30, 2010 | |||||||||||
|
REVENUES
|
$ | - | $ | - | $ | - | |||||||
|
EXPENSES
|
|||||||||||||
|
Sales and administrative expenses
|
4,607 | 3,991 | 217,915 | ||||||||||
|
Amoritization
|
189 | 189 | 4,199 | ||||||||||
|
|
|||||||||||||
|
NET LOSS FROM OPERATIONS
|
$ | (4,796 | ) | $ | (4,180 | ) | $ | (222,114 | ) | ||||
|
Other Expenses
|
|||||||||||||
|
Interest
|
(1,322 | ) | (1,076 | ) | (12,510 | ) | |||||||
|
NET LOSS
|
$ | (6,118 | ) | $ | (5,256 | ) | $ | (234,624 | ) | ||||
|
NET LOSS PER COMMON SHARE
|
|||||||||||||
|
Basic and diluted
|
$ | - | $ | - | |||||||||
|
WEIGHTED AVERAGE OUTSTANDING SHARES
|
|||||||||||||
|
Basic and diluted (stated in 1000's)
|
35,032 | 35,032 | |||||||||||
| The accompanying notes are an integral part of these financial statements. | |||||||||||||
| BRAIN TREE INTERNATIONAL, INC. | ||||||||||||
| (A Development Stage Company) | ||||||||||||
| STATEMENTS OF CASH FLOWS - unaudited | ||||||||||||
| For the Three Months Ended September 30, 2010 and 2009 | ||||||||||||
| and the period July 26, 1983 (date of inception) to September 30, 2010 | ||||||||||||
|
|
July 26, 1983
|
|||||||||||
| to | ||||||||||||
|
Sept 30, 2010
|
Sept 30, 2009
|
September 30, 2010
|
||||||||||
|
CASH FLOWS FROM
|
||||||||||||
|
OPERATING ACTIVITIES
|
||||||||||||
|
Net Loss
|
$ | (6,118 | ) | $ | (5,256 | ) | $ | (234,624 | ) | |||
|
Adjustments to reconcile net loss to
|
||||||||||||
|
net cash provided by operating activities
|
||||||||||||
|
Stock issued for services
|
- | - | 24,726 | |||||||||
|
Amortization
|
189 | 189 | 4,199 | |||||||||
|
Changes in accounts payable
|
2,536 | (900 | ) | 5,550 | ||||||||
| Changes in accrued interest payable - related party | 1,322 | 1,076 | 12,510 | |||||||||
|
Net Cash (used in) Operating Activities
|
(2,071 | ) | (4,891 | ) | (187,639 | ) | ||||||
|
CASH FLOWS FROM INVESTING ACTIVITIES
|
||||||||||||
|
Purchase of patent
|
- | (1,100 | ) | (13,646 | ) | |||||||
|
Net Cash (used in) Investing Activities
|
- | (1,100 | ) | (13,646 | ) | |||||||
|
CASH FLOWS FROM FINANCING ACTIVITIES
|
||||||||||||
|
Proceeds from note payable-related party
|
- | - | 65,000 | |||||||||
|
Contributions to capital
|
- | - | 3,698 | |||||||||
|
Proceeds from issuance of common stock
|
- | - | 135,854 | |||||||||
|
Net Cash provided by Financing Activities
|
- | - | 204,552 | |||||||||
|
Net Change in Cash
|
(2,071 | ) | 5,991 | 3,267 | ||||||||
|
Cash at Beginning of Period
|
5,338 | 7,488 | - | |||||||||
|
Cash at End of Period
|
$ | 3,267 | $ | 1,497 | $ | 3,267 | ||||||
|
SUPPLEMENTAL DISCLOSURE OF NONCASH
|
||||||||||||
|
FINANCING ACTIVITIES:
|
||||||||||||
|
Stock issued for services
|
$ | 24,726 | ||||||||||
| The accompanying notes are an integral part of these financial statements. | ||||||||||||
|
7.
|
SUBSEQUENT EVENTS
|
|
|
!
|
the sufficiency of existing capital resources and the ability to raise additional capital to fund cash requirements for future operations;
|
|
|
!
|
the ability to complete development of our technology;
|
|
|
!
|
the ability to secure necessary broadcast license, if required;
|
|
|
!
|
uncertainties involved in the rate of growth of our business and acceptance of our technology;
|
|
|
!
|
anticipated size or trends of the market segments in which we will compete and the anticipated competition in those markets;
|
|
|
!
|
volatility of the stock market; and
|
|
|
!
|
general economic conditions.
|
|
|
Exhibit 31.1
|
Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
Exhibit 31.2
|
Certification of Principal Financial Officer and Principal Accounting Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
Exhibit 32.1
|
Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
Exhibit 32.2
|
Certification of Principal Financial Officer and Principal Accounting Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
BRAIN TREE INTERNATIONAL, INC.
|
|
Date: November 15, 2010
|
By:
/S/ Donna T. Norman
|
|
Donna T. Norman
|
|
|
President, C.E.O. and Director
|
|
|
Date: November 15, 2010
|
By:
/S/ George I. Norman, III
|
|
George I. Norman, III
|
|
|
Vice President and Director
|
|
|
(Principal Financial Officer)
|
|
|
(Principal Accounting Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|